US · USD
CGON
CG Oncology, Inc. Common stock
- Day's range
- $61.90 – $63.64
- Day's volume
- $38.8M
- 52-week range
- $37.37 – $80.68
Follow CGON in the Fuolio
See how CGON weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountCGON in numbers
- Market cap
- $5.5B
- P/E
- -24.64
- P/B
- 5.37
- Dividend yield (12m)
- 0.00%
CGON price history
CGON risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months |
|---|---|
| Return | +39.12% |
| Volatility (annualized) | 38.77% |
| Largest drawdown | -17.00% |
| Positive months | 6/12 |
How much did investing in CGON return?
$1,000.00 invested on 02/01/2024 would be worth $1,395.21 today.
- Value today in CGON
- $1,395.21
- Return over the period
- +39.52%
- Return per year
- +13.23%
- In the S&P 500
- $1,530.88
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
CGON fundamentals
Valuation
- P/E-24.64
- P/B5.37
- EV/EBITDA-18.04
- EV/EBIT-17.83
- EV/Revenue723.20
- P/EBIT-21.89
- P/S887.83
- P/OCF-30.98
- P/FCF-30.83
- Earnings yield-5.61%
- PEG ratio—
- Earnings per share-$2.53
- Book value per share$11.61
Debt
- Net debt-$1B
- Net debt/EBITDA—
- Net debt/Equity-1.00
- Debt/Equity0.00
- Current ratio22.22
- Quick ratio22.20
- Cash ratio21.77
Efficiency
- Gross margin—
- EBITDA margin-4,008.72%
- Operating margin-4,056.18%
- Net margin-3,602.76%
- Asset turnover0.01
Profitability
- ROE-21.80%
- ROA-20.67%
- ROIC-4,341.89%
- Payout—
Growth
- Revenue CAGR (5 years)35.91%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
CGON's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 |
|---|---|---|---|
| P/E | -21.77 | -24.83 | — |
| P/B | 4.66 | 2.98 | — |
| Earnings per share | -$1.91 | -$1.16 | — |
| Book value per share | $8.91 | $9.62 | — |
| ROE | -21.39% | -12.00% | 39.49% |
| ROIC | -936.35% | — | — |
| EBITDA margin | -4,686.36% | -10,064.44% | -27,172.55% |
| Net margin | -3,985.15% | -7,729.59% | -23,826.96% |
CGON's financial statements
| Line | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net revenue | $4M | $1.1M | $204K |
| Cost of revenue | — | — | — |
| Gross profit | — | — | — |
| EBITDA | -$189.3M | -$114.6M | -$55.4M |
| EBIT | -$190.8M | -$114.7M | -$55.4M |
| Financial result | $29.8M | $26.6M | $6.8M |
| Income before tax | — | — | — |
| Income tax | $270K | -$1K | -$1K |
| Net income | -$161M | -$88M | -$48.6M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does CGON pay dividends?
CGON has no distributions on record.
About Cg Oncology
- Sector
- Manufacturing
Questions about CGON
How much is CGON today?
CGON is at $62.38 (-1.98% on the day), last traded on 10/07/2026.
What are the P/E and P/B of CGON?
CGON trades at a P/E of -24.64 and a P/B of 5.37.
How much did CGON return in 12 months?
CGON returned 39.12% in 12 months, with annualized volatility of 38.77% and a largest drawdown of -17.00%.